Qube Research & Technologies (QRT)’s Intra-Cellular Therapies Inc. ITCI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-931,330
| Closed | -$123M | – | 4096 |
|
|
2025
Q1 | $123M | Buy |
931,330
+677,633
| +267% | +$84.4M | 0.14% | 175 |
|
|
2024
Q4 | $21.2M | Buy |
253,697
+56,838
| +29% | +$4.67M | 0.03% | 697 |
|
|
2024
Q3 | $14.4M | Sell |
196,859
-81,715
| -29% | -$6.14M | 0.02% | 824 |
|
|
2024
Q2 | $19.1M | Buy |
278,574
+190,196
| +215% | +$13.2M | 0.03% | 619 |
|
|
2024
Q1 | $6.12M | Buy |
88,378
+78,180
| +767% | +$5.37M | 0.01% | 1116 |
|
|
2023
Q4 | $730K | Sell |
10,198
-46,091
| -82% | -$2.65M | ﹤0.01% | 2097 |
|
|
2023
Q3 | $2.93M | Buy |
56,289
+43,385
| +336% | +$2.53M | 0.01% | 1187 |
|
|
2023
Q2 | $817K | Sell |
12,904
-19,165
| -60% | -$1.19M | ﹤0.01% | 1381 |
|
|
2023
Q1 | $1.74M | Buy |
+32,069
| New | +$1.55M | 0.01% | 1066 |
|
|
2021
Q3 | – | Sell |
-10,046
| Closed | -$410K | – | 2887 |
|
|
2021
Q2 | $410K | Sell |
10,046
-13,114
| -57% | -$485K | ﹤0.01% | 1387 |
|
|
2021
Q1 | $786K | Sell |
23,160
-27,523
| -54% | -$955K | 0.01% | 954 |
|
|
2020
Q4 | $1.61M | Buy |
50,683
+36,607
| +260% | +$962K | 0.02% | 703 |
|
|
2020
Q3 | $361K | Buy |
+14,076
| New | +$321K | 0.01% | 1164 |
|
Other funds holding ITCI
KIM
HNB